Stay updated on Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial

Sign up to get notified when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:08:09.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Updated the Study Record Dates with a new last update posted on 2026-02-24 and a new last update submitted on 2026-02-20. Older dates (e.g., 2025-01-08, 2025-01-06) were removed.
    Difference
    0.3%
    Check dated 2026-02-27T18:41:13.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page shows a minor version update from v3.4.1 to v3.4.2 with no visible changes to trial information or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:58:54.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page update is limited to a revision notice from v3.4.0 to v3.4.1; there are no changes to study details or user workflows. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:09:12.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. This appears to be an internal version update with no changes to the study details or displayed information.
    Difference
    0.0%
    Check dated 2026-01-15T04:54:46.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a Locations section highlighting Ohio as the study site (Columbus, Ohio) and updated the page revision to v3.3.3. The prior Ohio Locations reference and the HHS Vulnerability Disclosure link were removed (revision: v3.3.2).
    Difference
    0.2%
    Check dated 2025-12-24T14:28:48.000Z thumbnail image

Stay in the know with updates to Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.